Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors
- 1 June 1991
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 337 (8755) , 1435-1439
- https://doi.org/10.1016/0140-6736(91)93126-t
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- High Rate of HTLV-II Infection in Seropositive IV Drug Abusers in New OrleansScience, 1989
- Seroprevalence and Epidemiological Correlates of HTLV-I Infection in U.S. Blood DonorsScience, 1988
- Chronic progressive myelopathy associated with elevated antibodies to human T‐lymphotropic virus type I and adult T‐cell leukemialike cellsAnnals of Neurology, 1987
- A Second Isolate of HTLV-II Associated with Atypical Hairy-Cell LeukemiaNew England Journal of Medicine, 1986
- Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic regionJAMA, 1986
- Regional variation in prevalence of antibody against human T‐lymphotropic virus types I and III in Kenya, East AfricaInternational Journal of Cancer, 1985
- Seroepidemilogy of human T-lymphotropic retrovirus type I (HTLV-I) in residents of niigata prefecture, Japan. Comparative studies by indirect immunofluorescence microscopy and enzyme-linked immunosorbent assayInternational Journal of Cancer, 1985
- LOW PREVALENCE IN THE UK OF HTLV-I AND HTLV-II INFECTION IN SUBJECTS WITH AIDS, WITH EXTENDED LYMPHADENOPATHY, AND AT RISK OF AIDSThe Lancet, 1984
- Epidemiology of Human T-Cell Leukemia/Lymphoma VirusThe Journal of Infectious Diseases, 1983
- The human type‐C retrovirus, HTLV, in blacks from the Caribbean region, and relationship to adult T‐cell leukemia/lymphomaInternational Journal of Cancer, 1982